HemoSonics
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, HemoSonics sits in the top decile of US sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count).
HemoSonics: 24 sponsored US clinical trials, none currently recruiting.
HemoSonics sponsors 24 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 21 completed. The most-studied condition in this pipeline is Blood Loss Massive, with 2 trials.
Top-decile sponsor footprint
HemoSonics ranks in the top decile of sponsors by registered trial count (#648 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
21 of 22 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Indexed trials (enrollment closed)
24 total, page 1 of 1
Quantra QPlus in Pediatric Cardiovascular Procedures
NCT07597278
Reference Range Study for the Quantra System With the QPlus Cartridge in Pediatric Patients
NCT07447713
QStat Cartridge in Obstetric Patients
NCT06255496
Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients
NCT06415760
Quantra QStat Sample Type Comparison
NCT06025708
Evaluation of the Quantra QStat System in Obstetric Patients
NCT05875987
QPlus Pediatric Reference Interval
NCT05645133
Exploratory Assessment of the Quantra® System in Adult ECMO Patients
NCT05426564
Quantra QPlus Sample Type Comparison
NCT05290675
Use of the Quantra QPlus Sytem in Cardiac Surgery
NCT05501730
Coagulation Changes Associated With COVID-19 Infection
NCT04460664
Quantra QStat in Trauma and Liver Transplant
NCT04312958
Reference Range Study for the Quantra QStat System
NCT04219371
QStat in Trauma and Obstetric Hemorrhage
NCT04385953
QStat in Liver Transplant
NCT04114253
Evaluation of the Quantra System in a Surgical Oncological Population
NCT04116385
HemoSonics - UTMB Cardiac Surgery Study
NCT03988465
Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge in Trauma
NCT03934983
Pre-surgical Evaluation for the Quantra System in Adult Patients Undergoing Cardiac Surgery
NCT03931031
Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge
NCT03912545
QStat Pilot Reference Range Study
NCT04490759
Evaluation of the Clinical Performance of the Quantra System With the Quantra Surgical Cartridge
NCT03152461
Reference Range Study for the Quantra Analyzer With the Quantra Surgical Cartridge
NCT03139097
Quantra Determination of Coagulation Parameters in Arterial and Venous Blood
NCT02978872
Therapeutic Areas
How the HemoSonics archive is shaped
24 indexed studies, none listed as recruiting (0% open); 21 completed (88%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Blood Loss Massive (2 trials), 6 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
HemoSonics: archived-pipeline peers nationwide
Peers matched on 24 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
HemoSonics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 24 archived trials
- Acrotech Biopharma · 24 trials · 8% recruiting
- Agenus · 24 trials · 0% recruiting
- Akebia Therapeutics · 24 trials · 4% recruiting
- Blueprint Medicines Corporation · 24 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this HemoSonics page
24 registered trials is a research-attention snapshot, not an endorsement of HemoSonics or any single study.
- None of HemoSonics's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Blood Loss Massive is the condition HemoSonics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Blood Loss Massive trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
HemoSonics pipeline card: 24 registered trials from official public datasets.Report a data error.